Archives
IgA Nephropathy – From Pathogenesis to Current Management
About This Event
IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. During this presentation you will learn the clinical presentation, diagnosis, prognosis, and unmet treatment needs of IgAN. You will then take a deep dive into the current understanding of IgAN pathogenesis including the four hit cascade and the key role B-cells and APRIL (A PRoliferation-Inducing Ligand) play in driving disease progression.
Americana
Las Vegas, NV 89128 United States + Google Map
Featuring
Rim Hadgu, PharmD, BCPS
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Dr Rim Hadgu, PharmD, BCPS is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She obtained her Doctor of Pharmacy degree from St. Louis College of Pharmacy. She completed an American Society of Health-System Pharmacists (ASHP)-Accredited PGY1 Pharmacy Residency at Xavier University of Louisiana College of Pharmacy and University Medical Center New Orleans. She also completed an ASHP-Accredited PGY2 Nephrology Pharmacy Residency at Albany College of Pharmacy and Health Sciences. Prior to joining Otsuka in October 2021, she was an Assistant Professor of Pharmacy Practice at Midwestern University College of Pharmacy, Glendale Campus where she delivered lectures, precepted Advanced Pharmacy Practice Experience students as well as PGY1 and PGY2 pharmacy residents. She also practiced as a nephrology clinical pharmacist for two years. Dr Hadgu is a Board Certified Pharmacotherapy Specialist by the Board of Pharmacy Specialties.
Dr. Samuel Kantor, MD
Nephrologist Partner
Samuel Kantor, MD
Nephrologist Partner
Nevada Kidney Disease and Hypertension Centers*
Dr Kantor received his postgraduate training at Medical College of Pennsylvania and Hahnemann University College of Medicine in Philadelphia, PA. Dr Kantor did his fellowship training at Drexel University College of Medicine in Philadelphia, PA and was Chief Nephrology Fellow. He is a partner at Nevada Kidney Disease and Hypertension Centers in Las Vegas, NV and is a principal investigator and sub-investigator in multiple phase 2 and 3 clinical studies undertaken by the practice. Dr Kantor has been board-certified in Nephrology since 2003. He was awarded ‘Top Doctor’ Status by Las Vegas INC. Magazine in their healthcare issue in 2015, 2016, and 2023. He was also awarded ‘Top Doctor’ status by Desert Companion Magazine in 2021 and 2022.
Rim Hadgu, PharmD, BCPS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Samuel Kantor, MD is a speaker on behalf of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
